In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Predictive and Presymptomatic Testing
... 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 12.7% CAGR The Predictive and Presymptomatic Testing market ... Read More
-
Protein Binding Assays
... at a CAGR of 9.4% over the analysis period 2024-2030. Equilibrium Dialysis, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$342.2 Million by the end of ... Read More
-
Service Laboratories
... CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$31.3 Billion While China is Forecast to Grow at 4.0% CAGR The Service Laboratories market in the U.S. is estimated at ... Read More
-
Automated Immunoassay Analyzers
... at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Urinalysis
... 5.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in ... Read More
-
Veterinary Diagnostics
... CAGR of 7.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.6 Billion by the end of the analysis period. ... Read More
-
Western Blotting
... CAGR of 5.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 Billion by ... Read More
-
Pneumonia Therapeutics
... CAGR of 6.7% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis period. ... Read More
-
Slide Stainers
... CAGR of 9.5% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$6.4 Billion by the end of the analysis period. ... Read More
-
Microbiology Culture
... CAGR of 3.8% over the analysis period 2024-2030. Eukaryotic Culture, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.2 Billion by the end of the analysis ... Read More
-
Drugs of Abuse Testing
... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Analyzers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.9 Billion by the end ... Read More
-
Leukapheresis
... 7.0% over the analysis period 2024-2030. Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$122.6 Million by the end of the analysis period. Growth in ... Read More
-
Blood Banking and Blood Products
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Blood Components & Plasma Products, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and ... Read More
-
Biochemistry Analyzers
... CAGR of 5.4% over the analysis period 2024-2030. Clinical Diagnostics Application, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.4 Billion by the end of the ... Read More
-
Cell Lysis / Cell Fractionation
... Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cell Lysis / Cell Fractionation Consumables, one of the segments analyzed in the report, is expected to record a 6.7% CAGR ... Read More
-
Cell Signaling
... CAGR of 5.4% over the analysis period 2024-2030. Cell Signaling Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$4.5 Billion by the end of the ... Read More
-
Endocrine Testing
... CAGR of 5.0% over the analysis period 2024-2030. Thyroid Stimulating Hormone (TSH) Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.3 Billion by the end ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
Laboratory Automated Incubators
... at a CAGR of 4.0% over the analysis period 2024-2030. Pharma & Biotech Companies, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$399.4 Million by the ... Read More
-
Ovulation Test
... CAGR of 4.0% over the analysis period 2024-2030. Urine, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Viral Hepatitis and Retrovirus Diagnostic Tests
... reach US$7.7 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 11.3% CAGR The Viral ... Read More
-
Oncology Companion Diagnostics Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Measuring Instrument Manufacturers & Suppliers (UK) - Industry Report
... heading for failure • Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Measuring Instrument Manufacturers & Suppliers ... Read More
-
Medical Microbiology Testing Technologies
... 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Respiratory Diseases, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by the ... Read More
Research Assistance
